Showing 1 posts of 1 posts found.
The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland